Corteva [CTVA] vs FMC [FMC] Detailed Stock Comparison
Corteva
NYSE
Loading...
FMC
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Corteva wins in 13 metrics, FMC wins in 7 metrics, with 0 ties. Corteva appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Corteva | FMC | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.07 | 37.13 | Corteva |
| Price-to-Book Ratio | 1.88 | 1.10 | FMC |
| Debt-to-Equity Ratio | 13.88 | 96.81 | Corteva |
| PEG Ratio | 1.22 | -0.48 | FMC |
| EV/EBITDA | 14.14 | 11.23 | FMC |
| Profit Margin (TTM) | 8.16% | 2.42% | Corteva |
| Operating Margin (TTM) | 28.28% | 15.53% | Corteva |
| EBITDA Margin (TTM) | 28.28% | 15.53% | Corteva |
| Return on Equity | 5.74% | 2.93% | Corteva |
| Return on Assets (TTM) | 3.55% | 3.08% | Corteva |
| Free Cash Flow (TTM) | $1.55B | $603.20M | Corteva |
| Dividend Yield | 0.69% | 5.57% | FMC |
| 1-Year Return | 31.27% | -41.04% | Corteva |
| Price-to-Sales Ratio (TTM) | 2.84 | 1.17 | FMC |
| Enterprise Value | $50.46B | $8.70B | Corteva |
| EV/Revenue Ratio | 2.94 | 2.11 | FMC |
| Gross Profit Margin (TTM) | 54.58% | 38.68% | Corteva |
| Revenue per Share (TTM) | $25 | $33 | FMC |
| Earnings per Share (Diluted) | $2.17 | $1.04 | Corteva |
| Beta (Stock Volatility) | 0.75 | 0.76 | Corteva |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Corteva vs FMC Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Corteva | 0.77% | 0.87% | -0.05% | 5.46% | 14.30% | 29.50% |
| FMC | -0.16% | 2.69% | -8.26% | -5.00% | 0.94% | -20.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Corteva | 31.27% | 17.07% | 147.15% | 151.59% | 151.59% | 151.59% |
| FMC | -41.04% | -66.16% | -64.68% | 4.84% | 40.95% | 215.47% |
Performance & Financial Health Analysis: Corteva vs FMC
| Metric | CTVA | FMC |
|---|---|---|
| Market Information | ||
| Market Cap | $48.73B | $4.82B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 4,718,230 | 1,855,560 |
| 90 Day Avg. Volume | 4,096,903 | 1,813,797 |
| Last Close | $72.96 | $38.55 |
| 52 Week Range | $53.40 - $77.41 | $32.83 - $67.75 |
| % from 52W High | -5.75% | -43.10% |
| All-Time High | $77.41 (Jul 03, 2025) | $140.99 (Apr 18, 2022) |
| % from All-Time High | -5.75% | -72.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.01% |
| Quarterly Earnings Growth | 0.25% | -0.77% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.02% |
| Operating Margin (TTM) | 0.28% | 0.16% |
| Return on Equity (TTM) | 0.06% | 0.03% |
| Debt to Equity (MRQ) | 13.88 | 96.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $38.11 | $35.20 |
| Cash per Share (MRQ) | $3.15 | $3.51 |
| Operating Cash Flow (TTM) | $3.14B | $31.90M |
| Levered Free Cash Flow (TTM) | $2.48B | $374.39M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.69% | 5.57% |
| Last 12-Month Dividend | $0.51 | $2.32 |
Valuation & Enterprise Metrics Analysis: Corteva vs FMC
| Metric | CTVA | FMC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.07 | 37.13 |
| Forward P/E | 22.36 | 8.29 |
| PEG Ratio | 1.22 | -0.48 |
| Price to Sales (TTM) | 2.84 | 1.17 |
| Price to Book (MRQ) | 1.88 | 1.10 |
| Market Capitalization | ||
| Market Capitalization | $48.73B | $4.82B |
| Enterprise Value | $50.46B | $8.70B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.94 | 2.11 |
| Enterprise to EBITDA | 14.14 | 11.23 |
| Risk & Other Metrics | ||
| Beta | 0.75 | 0.76 |
| Book Value per Share (MRQ) | $38.11 | $35.20 |
Financial Statements Comparison: Corteva vs FMC
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CTVA | FMC |
|---|---|---|
| Revenue/Sales | $4.42B | $791.40M |
| Cost of Goods Sold | $2.34B | $474.70M |
| Gross Profit | $2.08B | $316.70M |
| Research & Development | $335.00M | $68.70M |
| Operating Income (EBIT) | $827.00M | $76.00M |
| EBITDA | $1.16B | $116.50M |
| Pre-Tax Income | $784.00M | $4.90M |
| Income Tax | $117.00M | $13.50M |
| Net Income (Profit) | $656.00M | $-15.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CTVA | FMC |
|---|---|---|
| Cash & Equivalents | $2.01B | $315.30M |
| Total Current Assets | $16.59B | $5.08B |
| Total Current Liabilities | $11.48B | $3.31B |
| Long-Term Debt | $1.79B | $3.03B |
| Total Shareholders Equity | $24.53B | $4.41B |
| Retained Earnings | $587.00M | $6.55B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CTVA | FMC |
|---|---|---|
| Operating Cash Flow | $-2.11B | $-672.60M |
| Capital Expenditures | $8.00M | N/A |
| Free Cash Flow | $-2.20B | $-589.90M |
| Debt Repayment | $-14.00M | N/A |
| Common Stock Repurchase | $-270.00M | $-1.40M |
Short Interest & Institutional Ownership Analysis
| Metric | CTVA | FMC |
|---|---|---|
| Shares Short | 5.64M | 6.30M |
| Short Ratio | 1.57 | 3.77 |
| Short % of Float | 0.01% | 0.06% |
| Average Daily Volume (10 Day) | 4,718,230 | 1,855,560 |
| Average Daily Volume (90 Day) | 4,096,903 | 1,813,797 |
| Shares Outstanding | 685.60M | 124.84M |
| Float Shares | 677.34M | 123.90M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.87% | 0.97% |
Dividend Analysis & Yield Comparison: Corteva vs FMC
| Metric | CTVA | FMC |
|---|---|---|
| Last 12-Month Dividend | $0.51 | $2.32 |
| Last 12-Month Dividend Yield | 0.69% | 5.57% |
| 3-Year Avg Annual Dividend | $0.58 | $2.29 |
| 3-Year Avg Dividend Yield | 0.28% | 0.83% |
| 3-Year Total Dividends | $1.74 | $6.86 |
| Ex-Dividend Date | Mar 03, 2025 | Mar 31, 2025 |